Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Epilepsy & Behavior

• Publication date

  2013-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.yebeh.2012.10.009PMID 23395350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

  2012cited by this paper
• Preclinical antiepileptic actions of selective serotonin reuptake inhibitors—Implications for clinical trial design

  2012cited by this paper
• The role of glutamate on the action of antidepressants.

  2011cited by this paper
• Glutamatergic drive of the dorsal raphe nucleus.

  2011cited by this paper
• The serotonin axis: Shared mechanisms in seizures, depression, and SUDEP

  2011cited by this paper
• Comorbidity between epilepsy and depression: Experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms

  2010cited by this paper
• Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

  2009cited by this paper
• Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

  2008cited by this paper
• Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus.

  2008cited by this paper
• 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression.

  2007influential reference
• Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports.

  2007cited by this paper
• The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

  2007cited by this paper
• Lateral habenula as a source of negative reward signals in dopamine neurons

  2007cited by this paper
• Serotonin and epilepsy

  2007cited by this paper
• Psychiatric Comorbidity in Epilepsy: A Population‐Based Analysis

  2007cited by this paper
• Depression and Attempted Suicide as Risk Factors for Incident Unprovoked Seizures and Epilepsy

  2006cited by this paper
• Depression and suicide attempt as risk factors for incident unprovoked seizures

  2006cited by this paper
• The Effect of Antiepileptic Drugs on 5‐HT1A–Receptor Binding Measured by Positron Emission Tomography

  2006influential reference
• Quantitative in Vivo Microdialysis Study on the Influence of Multidrug Transporters on the Blood-Brain Barrier Passage of Oxcarbazepine: Concomitant Use of Hippocampal Monoamines as Pharmacodynamic Markers for the Anticonvulsant Activity

  2005cited by this paper
• 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats.

  2005cited by this paper
• Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy.

  2005cited by this paper
• Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.

  2005cited by this paper
• Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.

  2005cited by this paper
• 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats.

  2005cited by this paper
• Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy

  2004cited by this paper
• Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5‐HT1A receptors

  2004cited by this paper
• Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy.

  2004cited by this paper
• 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study.

  2004cited by this paper
• Citalopram as Treatment of Depression in Patients With Epilepsy

  2004cited by this paper
• Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice.

  2004cited by this paper
• The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis.

  2003cited by this paper
• PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

  2003cited by this paper
• Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities

  2002cited by this paper
• Major depression is a risk factor for seizures in older adults

  2000cited by this paper
• Negative Immunoregulatory Effects of Antidepressants: Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

  1999cited by this paper
• A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders.

  1999cited by this paper
• Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats.

  1998cited by this paper
• Carbamazepine‐Induced Release of Serotonin from Rat Hippocampus In Vitro

  1998cited by this paper
• Sound-induced seizures in serotonin 5-HT2c receptor mutant mice

  1997cited by this paper
• Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+.

  1997cited by this paper
• Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice

  1997cited by this paper
• Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.

  1997cited by this paper
• Further evidence of anticonvulsant role for 5‐hydroxytryptamine in genetically epilepsy‐prone rats

  1995cited by this paper
• Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).

  1995cited by this paper
• Anticonvulsant effect of fluoxetine in humans

  1995cited by this paper
• 5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells.

  1994cited by this paper
• Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.

  1994cited by this paper
• International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

  1994cited by this paper
• Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats.

  1993cited by this paper
• Seizures associated with antidepressants: a review.

  1993cited by this paper
• Anticonvulsant Effect of Fluoxetine on Focally Evoked Limbic Motor Seizures in Rats

  1993cited by this paper
• Recent advances in the electrophysiological characterization of 5-HT3 receptors.

  1992cited by this paper
• 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.

  1992cited by this paper
• Tricyclic antidepressant-induced seizures and plasma drug concentration.

  1992cited by this paper
• Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats.

  1992cited by this paper
• Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release.

  1992cited by this paper
• 5-Hydroxytryptamine hyperpolarizes CA3 hippocampal pyramidal cells through an increase in potassium conductance.

  1991cited by this paper
• The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo.

  1991cited by this paper
• An incident case-referent study of epileptic seizures in adults.

  1990cited by this paper
• Seizures and bupropion: a review.

  1989cited by this paper
• Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations.

  1988cited by this paper
• Imipramine in absence and myoclonic‐astatic seizures

  1978cited by this paper
• Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat.

  1973cited by this paper

• A unified hypothesis of SUDEP: Seizure‐induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray

  2023cites this paper
• Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding

  2023cites this paper
• Impact of Vortioxetine with antiepileptic drugs combined administration on non- convulsive behaviour in kindled rats

  2023cites this paper
• Unravelling the neurochemical maze: neurotransmitters, neuropeptides and novel drug modes of action based on epilepsy pathophysiology

  2023cites this paper
• A nationwide study of initiation of antidepressant pharmacotherapy and the risk of seizures.

  2023cites this paper
• Suicidality in Patients With Epilepsy: Why Should Neurologists Care?

  2022cites this paper
• Association of TPH1 and TPH2 Gene Polymorphisms with the Risk of Developing Psychoneurological Disorders

  2022cites this paper
• Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine?

  2022cites this paper
• Association of TPH1 and TPH2 Gene Polymorphisms with the Risk of Developing Psychoneurological Disorders

  2022cites this paper
• Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy

  2022cites this paper
• Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand?

  2022cites this paper
• Neurochemical Effects of 4-(2Chloro-4-Fluorobenzyl)-3-(2-Thienyl)-1,2,4-Oxadiazol-5(4H)-One in the Pentylenetetrazole (PTZ)-Induced Epileptic Seizure Zebrafish Model

  2021cites this paper
• Antidepressants for people with epilepsy and depression.

  2021cites this paper
• Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats

  2021cites this paper
• Bidirectional Relations Among Depression, Migraine, and Epilepsy: Do They Have an Impact on Their Response to Treatment?

  2021cites this paper
• Do Psychotropic Drugs Cause Epileptic Seizures? A Review of the Available Evidence.

  2021cites this paper
• Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know.

  2021cites this paper
• Imipramine-precipitated status epilepticus

  2021cites this paper
• An unbiased drug screen for seizure suppressors in Dup15q syndrome reveals 5HT1A and dopamine pathway activation as potential therapies

  2020cites this paper
• Neurobiologic properties of mood disorders may have an impact on epilepsy: Should this motivate neurologists to screen for this psychiatric comorbidity in these patients?

  2019cites this paper
• Individualized treatment approaches: Fenfluramine, a novel antiepileptic medication for the treatment of seizures in Dravet syndrome.

  2019cites this paper
• Adult neurogenesis in the mouse dentate gyrus protects the hippocampus from neuronal injury following severe seizures

  2019cites this paper
• Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.

  2019cites this paper
• The Association between Serotonin Reuptake Inhibitors and Obstructive Sleep Apnea in People with Epilepsy-A Retrospective Analysis

  2018cites this paper
• Serotonergic mechanisms in the 6-Hz psychomotor seizures in mice

  2018cites this paper
• Pharmacological treatment of anxiety disorders in adults with epilepsy

  2018cites this paper
• Epilepsy and Psychiatric Comorbidities: Drug Selection

  2017cites this paper
• Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel

  2017cites this paper
• The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?

  2017cites this paper
• Use of Animal Models for Epilepsy Research and Therapy Development

  2017cites this paper
• Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy

  2017cites this paper
• Diagnosing and treating depression in epilepsy.

  2017cites this paper
• Musicogenic Epilepsy and Treatment of Affective Disorders: Case Report and Review of Pathogenesis.

  2016cites this paper
• The pharmacological management of psychiatric comorbidities in patients with epilepsy.

  2016cites this paper
• Proconvulsant effects of antidepressants - What is the current evidence?

  2016cites this paper
• The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs

  2016cites this paper
• Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.

  2016cites this paper
• Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs

  2016cites this paper
• The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups

  2016cites this paper
• Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model.

  2016cites this paper
• Effect of endurance training on seizure susceptibility, behavioral changes and neuronal damage after kainate-induced status epilepticus in spontaneously hypertensive rats.

  2015cites this paper
• Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome

  2015cites this paper
• Mental Health Perspectives of Epilepsy: Focus on Anxiety Disorders

  2015cites this paper
• Citalopram as a good candidate for treatment of depression in patients with epilepsy.

  2015influential citation
• Suppression of adult neurogenesis increases the acute effects of kainic acid.

  2015cites this paper
• Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive‐like behaviour in the WAG/Rij rat model of absence epilepsy

  2015influential citation
• Effects of AT1 receptor antagonism on kainate-induced seizures and concomitant changes in hippocampal extracellular noradrenaline, serotonin, and dopamine levels in Wistar-Kyoto and spontaneously hypertensive rats.

  2015cites this paper
• Depressive Disorders in Patients with Epilepsy: Underdiagnosed and Appropriately Managed?

  2015cites this paper
• Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats.

  2015cites this paper
• Sertraline Reduces IL-1β and TNF-α mRNA Expression and Overcomes Their Rise Induced by Seizures in the Rat Hippocampus

  2014cites this paper
• Seizure reduction with fluoxetine in an adult woman with Dravet syndrome

  2014cites this paper
• Comments on Kanner AM et al. The use of sertraline in patients with epilepsy: is it safe? Epilepsy & Behavior 2000;1:100-105.

  2014cites this paper
• Sensory Attenuation Assessed by Sensory Evoked Potentials in Functional Movement Disorders

  2014cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM NEUROCIÊNCIAS E BIOLOGIA CELULAR

  2014cites this paper
• WITHDRAWN: Proconvulsant effects of antidepressants: What is the current evidence?

  2014cites this paper
• Serotonin neurones have anti‐convulsant effects and reduce seizure‐induced mortality

  2014cites this paper
• VEEG models of seizure frequency--do SSRI medications or vitamin D supplements alter seizure collections?

  2014cites this paper
• Antiepileptic drugs patterns in elderly inpatients in a Brazilian tertiary center, Salvador, Brazil.

  2014cites this paper
• Serotonin and Epilepsy: The Story Continues

  2013cites this paper
• Serotonin and Epilepsy: The Story Continues

  2013cites this paper